Barrett's Esophagus and Medications that Relax the Lower Esophageal Sphincter

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Journal of Gastroenterology

• Publication date

  2006-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1572-0241.2006.00539.xPMID 16573773
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of isosorbide dinitrate on gastroesophageal reflux in healthy volunteers and patients with Chagas' disease

  2005cited by this paper
• Applied Logistic Regression: Hosmer/Applied Logistic Regression

  2005cited by this paper
• A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop.

  2004cited by this paper
• Relationship between body mass index, diet, exercise and gastro‐oesophageal reflux symptoms in a community

  2004cited by this paper
• Asthmatics Have More Nocturnal Gasping and Reflux Symptoms than Nonasthmatics, and They are Related to Bedtime Eating

  2004cited by this paper
• Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study.

  2004cited by this paper
• Statistical methods in cancer research

  2001cited by this paper
• Degree of Matching and Gain in Power and Efficiency in Case-Control Studies

  2001cited by this paper
• The effects of an inhaled beta(2)-adrenergic agonist on lower esophageal function: a dose-response study.

  2001cited by this paper
• Low Circulating Vitamin B6 Is Associated With Elevation of the Inflammation Marker C-Reactive Protein Independently of Plasma Homocysteine Levels

  2001cited by this paper
• The Effects of an Inhaled β2-Adrenergic Agonist on Lower Esophageal Function: A Dose-Response Study

  2001cited by this paper
• Effect of nifedipine administration (10 mg) on esophageal acid exposure time

  2000cited by this paper
• Felodipine does not increase the reflux episodes in patients with gastroesophageal reflux disease.

  2000cited by this paper
• Potential gain in efficiency and power to detect gene‐environment interactions by matching in case‐control studies

  2000cited by this paper
• Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and quality of life.

  2000cited by this paper
• The accuracy of body weight and height recall in middle-aged men

  2000cited by this paper
• Association between Medications That Relax the Lower Esophageal Sphincter and Risk for Esophageal Adenocarcinoma

  2000cited by this paper
• Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

  1999cited by this paper
• Diltiazem enhances tumor blood flow: MRI study in a murine tumor.

  1999cited by this paper
• Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy.

  1999cited by this paper
• Changing patterns in the incidence of esophageal and gastric carcinoma in the United States

  1998influential reference
• Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.

  1998cited by this paper
• Effects of 3‐days' intake of a sustained‐release preparation of the nitric oxide donor, isosorbide dinitrate, on oesophageal motility

  1997cited by this paper
• Validation of pharmacy records in drug exposure assessment.

  1997cited by this paper
• Do calcium channel blockers increase the risk of cancer?

  1996cited by this paper
• Rising incidence rate of esophageal adenocarcinoma and use of pharmaceutical agents that relax the lower esophageal sphincter (United States)

  1994influential reference
• Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology.

  1992cited by this paper
• The effects of inhaled albuterol and oral theophylline on gastroesophageal reflux in patients with gastroesophageal reflux disease and obstructive lung disease.

  1992cited by this paper
• Cholesterol and coronary artery disease: age as an effect modifier.

  1992cited by this paper
• The effect of intravenous diazepam on esophageal motility in normal subjects

  1991cited by this paper
• Effects of albuterol (salbutamol) on esophageal motility and gastroesophageal reflux in healthy volunteers.

  1988cited by this paper
• Effect of acepromazine, diazepam, fentanyl-droperidol, and oxymorphone on gastroesophageal sphincter pressure in healthy dogs.

  1987cited by this paper
• Nifedipine and esophageal dysfunction in progressive systemic sclerosis. A controlled manometric study.

  1985cited by this paper
• Epidemiologic Research: Principles and Quantitative Methods.

  1983cited by this paper
• Effect of theophylline on gastroesophageal reflux in normal adults.

  1981cited by this paper
• Effect of sublingual nitroglycerin and long-acting nitrate preparations on esophageal motility.

  1980influential reference
• Effect of diazepam on the lower esophageal sphincter. A double-blind controlled study.

  1980cited by this paper
• Statistical methods in cancer research: volume 1- The analysis of case-control studies

  1980cited by this paper
• Effect of diazepam on the lower esophageal sphincter. A double-blind controlled study.

  1980cited by this paper

• Genetic evidence for amlodipine’s protective role in gastroesophageal reflux disease: A focus on CACNB2

  2025cites this paper
• Risk Factors for the Development of Barrett's Esophagus and Esophageal Adenocarcinoma: A Systematic Review and Meta‐Analysis

  2025cites this paper
• Oral prednisolone and warfarin and risk of oesophageal cancer: A case-control study.

  2024cites this paper
• Esophageal cancer: Epidemiology, risk factors and screening

  2021cites this paper
• Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett’s Esophagus, and Esophageal Adenocarcinoma

  2019cites this paper
• Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer: An analysis of two independent population‐based databases

  2018cites this paper
• Erosive tooth wear – a review on global prevalence and on its prevalence in risk groups

  2018cites this paper
• Asthma COPD overlap: Impact of associated comorbidities.

  2018cites this paper
• Practical aspects of high resolution esophageal manometry.

  2016cites this paper
• Epidemiology and Risk Factors of Esophageal Cancer The THAI Journal of SURGERY

  2016cites this paper
• Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma.

  2015cites this paper
• REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

  2015cites this paper
• Quantification of population benefit in evaluation of biomarkers: practical implications for disease detection and prevention

  2014cites this paper
• Risk factors for the development of oesophageal adenocarcinoma in Barrett’s oesophagus: a UK primary care retrospective nested case–control study

  2014cites this paper
• Environmental–life style related factors

  2013cites this paper
• Studies of the aetiology of oesophageal adenocarcinoma

  2013cites this paper
• Meta-analysis: risk of esophageal adenocarcinoma with medications which relax the lower esophageal sphincter.

  2012cites this paper
• Does BMI affect the clinical efficacy of proton pump inhibitor therapy in GERD? The case for rabeprazole

  2011cites this paper
• Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.

  2011cites this paper
• Current Status and Future Perspectives on the Etiology of Esophageal Adenocarcinoma

  2011cites this paper
• Risk factors for erosive esophagitis: a cross-sectional study of a large number of Japanese males

  2011cites this paper
• Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications

  2010influential citation
• Adverse effects of drugs on the esophagus.

  2010cites this paper
• The role of gastro-oesophageal pressure gradient and sliding hiatal hernia on pathological gastro-oesophageal reflux in severely obese patients

  2010cites this paper
• Environmental - lifestyle related factors.

  2010cites this paper
• Best Practice & Research Clinical Gastroenterology

  2010cites this paper
• Meta-Analyses of the Effect of Symptoms of Gastroesophageal Reflux on the Risk of Barrett's Esophagus

  2010cites this paper
• The Relationship Between Visceral Adiposity and the Risk of Erosive Esophagitis in Severely Obese Chinese Patients

  2010cites this paper
• Impact of gastroesophageal reflux disease on the quality of life of Spanish patients: the relevance of the biometric factors and the severity of symptoms

  2009cites this paper
• The Prevalence and Clinical Characteristics of Reflux Esophagitis in Koreans and Its Possible Relation to Metabolic Syndrome

  2009cites this paper
• The Role of Gastroesophageal Reflux in Exercise-Triggered Asthma: A Randomized Controlled Trial

  2009cites this paper
• Clinical relevance of laparoscopically diagnosed hiatal hernia

  2009cites this paper
• Medication usage and the risk of neoplasia in patients with Barrett's esophagus.

  2009cites this paper
• A population-based study showing an association between gastroesophageal reflux disease and sleep problems.

  2009cites this paper
• Barrett's Esophagus and esophageal adenocarcinoma.

  2009cites this paper
• Exploring the association between elevated body mass index and Barrett's esophagus: a systematic review and meta-analysis.

  2009cites this paper
• Heartburn during sleep: a clinical marker of gastro‐oesophageal reflux disease in morbidly obese patients

  2009cites this paper
• Environmental causes of esophageal cancer.

  2009cites this paper
• Gastroesophageal reflux disease: An Asian perspective

  2008cites this paper
• The pathophysiologic basis for epidemiologic trends in gastroesophageal reflux disease.

  2008cites this paper
• Racial and Geographic Issues in Gastroesophageal Reflux Disease

  2008cites this paper
• The effect of anticholinergic agents on gastro-oesophageal reflux and related disorders

  2008cites this paper
• The Association Between Obesity and GERD: A Review of the Epidemiological Evidence

  2008cites this paper
• Pathogenesis of gastro‐oesophageal reflux disease and novel options for its therapy

  2008cites this paper
• Systematic review: persistence and severity in gastro‐oesophageal reflux disease

  2008cites this paper
• Developments in pathogenesis and diagnosis of gastroesophageal reflux disease

  2007cites this paper
• Barrett’s esophagus and esophageal adenocarcinoma in adults: Long-term GERD or something else?

  2007cites this paper
• Do Drugs or Bugs Cause GERD?

  2007cites this paper
• Non-Steroidal Anti-Inflammatory Drugs, Lower Oesophageal Sphincter-Relaxing Drugs and Oesophageal Cancer

  2007cites this paper
• Body mass index and GERD: Is the association that huge?

  2007cites this paper
• Barrett's Esophagus and Medications that Relax the Lower Esophageal Sphincter

  2007cites this paper
• Epidemiology and pathogenesis of esophageal cancer.

  2007cites this paper
• [Barrett carcinoma--diagnosis, screening, surveillance, endoscopic treatment, prevention].

  2007cites this paper
• Gastrointestinal and Nutritional Complications After Bariatric Surgery

  2007cites this paper
• Nocturnal Reflux Episodes Following the Administration of a Standardized Meal. Does Timing Matter?

  2007cites this paper
• Effets secondaires des médicaments: Des conséquences indésirables aux effets recherchés

  2006cites this paper
• Effets secondaires des médicaments : des conséquences indésirables aux effets recherchés Side effects of drugs : from unwanted to desirable effects

  2006cites this paper
• edication Usage and the Risk of Neoplasia in Patients ith Barrett ’ s Esophagus

  year unknowncites this paper